World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
36512
World Ranking
10399
National Ranking
411

Chris H. Bangma publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Chris H. Bangma sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 575 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Chris H. Bangma D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Chris H. Bangma sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 94 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Chris H. Bangma is affiliated with Erasmus University Rotterdam in the Netherlands. The primary focus of their research lies within the field of Medicine, with particular emphasis on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Oncology, Surgery, and Pathology and Forensic Medicine. Their work centers on prostate cancer and related diagnostic and treatment methods, as well as the application of radiomics and machine learning in medical imaging.

The main topics of Chris H. Bangma's research include:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Bladder and Urothelial Cancer Treatments
  • Global Cancer Incidence and Screening
  • Genetic factors in colorectal cancer
  • Renal cell carcinoma treatment

Frequent co-authors collaborating with Bangma comprise:

  • Monique J. Roobol
  • Ivo G. Schoots
  • Sebastiaan Remmers
  • Muhammad Arif
  • Jose M. Castillo T.

Bangma has contributed to several publication venues, notably:

  • European Urology
  • European Urology Open Science
  • European Urology Oncology
  • European Radiology
  • The Lancet Oncology

Among the recent papers published are:

  • "Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI" (2020, European Radiology)
  • "A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study" (2021, The Lancet Oncology)
  • "Radical prostatectomy versus deferred treatment for localised prostate cancer" (2020, Cochrane Database of Systematic Reviews)
  • "A Multi-Center, Multi-Vendor Study to Evaluate the Generalizability of a Radiomics Model for Classifying Prostate cancer: High Grade vs. Low Grade" (2021, Diagnostics)
  • "Classification of Clinically Significant Prostate Cancer on Multi-Parametric MRI: A Validation Study Comparing Deep Learning and Radiomics" (2021, Cancers)

Best Publications

  • Screening and Prostate-Cancer Mortality in a Randomized European Study

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

    Fritz H Schröder;Jonas Hugosson;Monique J Roobol;Teuvo L J Tammela

  • Prostate-Cancer Mortality at 11 Years of Follow-up

    Fritz H. Schröder;Jonas Hugosson;Monique J. Roobol;Stefano Ciatto

  • Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.

    Ivo G. Schoots;Monique J. Roobol;Daan Nieboer;Chris H. Bangma

  • Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

    Meelan Bul;Xiaoye Zhu;Riccardo Valdagni;Tom Pickles

  • A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

    William J. Catalona;Alan W. Partin;Martin G. Sanda;John T. Wei

  • Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer

    Frankâ€Jan H Drost;Daniël F Osses;Daan Nieboer;Ewout W Steyerberg

  • Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    A. Horwich;C. Parker;Chris Bangma;Vesa Kataja

  • A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

    Jonas Hugosson;Monique J. Roobol;Marianne Månsson;Teuvo L.J. Tammela

  • Quality-of-life effects of prostate-specific antigen screening.

    Eveline A M Heijnsdijk;Elisabeth M Wever;Anssi Auvinen;Jonas Hugosson

  • Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.

    Stacy Loeb;Suzanne van den Heuvel;Xiaoye Zhu;Chris H. Bangma

  • A Decade of Active Surveillance in the PRIAS Study : an Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment

    Leonard P. Bokhorst;Riccardo Valdagni;Antti Rannikko;Yoshiyuki Kakehi

  • A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.

    Monique J. Roobol;Ewout W. Steyerberg;Ries Kranse;Tineke Wolters

  • Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly.

    Roderick C.N. van den Bergh;Stijn Roemeling;Monique J. Roobol;Gunnar Aus

  • Exosomes as biomarker treasure chests for prostate cancer.

    Diederick Duijvesz;Theo Luider;Chris H. Bangma;Guido Jenster

  • Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection

    Flip H. Jansen;Ron H.N. van Schaik;Joep Kurstjens;Wolfgang Horninger

  • Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer

    E S Martens-Uzunova;S E Jalava;N F Dits;G J L H van Leenders

  • Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.

    Charlotte F Kweldam;Mark F. Wildhagen;Ewout W. Steyerberg;Chris H. Bangma

  • Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis

    Frank-Jan H. Drost;Daniel Osses;Daan Nieboer;Chris H. Bangma

  • Anxiety and distress during active surveillance for early prostate cancer.

    Roderick C. N. van den Bergh;Marie-Louise Essink-Bot;Marie-Louise Essink-Bot;Monique J. Roobol;Tineke Wolters

Frequent Co-Authors

Ewout W. Steyerberg
Ewout W. Steyerberg Leiden University Medical Center
Guido Jenster
Guido Jenster Erasmus University Rotterdam
Ellen C. Zwarthoff
Ellen C. Zwarthoff Erasmus University Rotterdam
Anssi Auvinen
Anssi Auvinen Tampere University
Ron H.N. van Schaik
Ron H.N. van Schaik Erasmus University Rotterdam
Arnauld Villers
Arnauld Villers University of Lille
Harry J. de Koning
Harry J. de Koning Erasmus University Rotterdam
Teuvo L.J. Tammela
Teuvo L.J. Tammela Tampere University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always mean following the traditional path through medical school. Online degree programs in nursing, for example, offer flexible options for students with different backgrounds and experience levels.

For registered nurses looking to advance their education, rn bsn online programs no clinicals provide a convenient solution, allowing RNs to earn their BSN without mandatory in-person clinical requirements. Those seeking advanced practice roles can explore dnp programs online for doctoral-level training and leadership preparation.

Cost is a common concern for many students. Options like cheapest online dnp programs can make higher-level nursing degrees more accessible. For those interested in starting their healthcare careers sooner, it’s important to consider what is the fastest way to become an lpn to quickly enter the workforce as a Licensed Practical Nurse.

Exploring these online pathways can help future healthcare professionals choose a route that best matches their goals, timeline, and budget.

Best Scientists Citing Chris H. Bangma

Trending Scientists